Podcast Medicom Medical Publishers

ACC.20/WCC virtual highlights - part 1 of 3

March 30, 2020 Medicom Medical Publishers
Podcast Medicom Medical Publishers
ACC.20/WCC virtual highlights - part 1 of 3
Chapters
0:17
Armstrong et al - VICTORIA trial
3:27
Bonaca et al - VOYAGER-PAD trial
6:18
Pereira et al - TAILOR-PCI trial
9:02
Leon et al - PARTNER 3 trial
11:28
Agnelli et al - CARAVAGGIO trial
14:34
Samama et al
Podcast Medicom Medical Publishers
ACC.20/WCC virtual highlights - part 1 of 3
Mar 30, 2020
Medicom Medical Publishers

Order of abstracts:

  1. Armstrong et al - VICTORIA trial - Vericiguat shows beneficial effects in very high-risk HF population
  2. Bonaca et al - VOYAGER-PAD trial - Rivaroxaban and aspirin effective and safe for PAD patients 
  3. Pereira et al - TAILOR-PCI trial - TAILOR-PCI misses endpoint but still provides valuable insights
  4. Leon et al - PARTNER 3 trial - 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis 
  5. Agnelli et al - CARAVAGGIO trial - Apixaban offers new perspective for cancer patients in need of anticoagulation 
  6. Samama et al - Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Show Notes Chapter Markers

Order of abstracts:

  1. Armstrong et al - VICTORIA trial - Vericiguat shows beneficial effects in very high-risk HF population
  2. Bonaca et al - VOYAGER-PAD trial - Rivaroxaban and aspirin effective and safe for PAD patients 
  3. Pereira et al - TAILOR-PCI trial - TAILOR-PCI misses endpoint but still provides valuable insights
  4. Leon et al - PARTNER 3 trial - 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis 
  5. Agnelli et al - CARAVAGGIO trial - Apixaban offers new perspective for cancer patients in need of anticoagulation 
  6. Samama et al - Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Armstrong et al - VICTORIA trial
Bonaca et al - VOYAGER-PAD trial
Pereira et al - TAILOR-PCI trial
Leon et al - PARTNER 3 trial
Agnelli et al - CARAVAGGIO trial
Samama et al